Skip to Content

WPI 2265 (Acitretin 22.5 mg)

Pill with imprint WPI 2265 is Brown, Capsule-shape and has been identified as Acitretin 22.5 mg. It is supplied by Actavis Pharma, Inc..

Acitretin is used in the treatment of psoriasis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 22.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2265

Acitretin

Imprint
WPI 2265
Strength
22.5 mg
Color
Brown
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antipsoriatics
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-2265
Inactive Ingredients
maltodextrin, sodium ascorbate, microcrystalline cellulose, gelatin, ferric oxide red, shellac, ferrosoferric oxide, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.